T-E Pharma Hosts Annual Year-End Gala as Five Drug Candidates Reach Key Development Milestones
T-E Pharma held its annual year-end gala on January 29, providing an overview of the Group’s R&D achievements and future […]
News Article
News Article
An Interview with Chairman Tse-Wen Chang, Founder of Immunwork and T-E Meds: A Journey Through Science and Entrepreneurship
Dr. Tse-Wen Chang, Chairman and Founder of Immunwork and T-E Meds, built his scientific career through National Tsing-Hua University, Harvard
Scientific Publication
Our Latest Research Published in Haematologica
Great news! Our latest publication presents TE-1146 as a novel therapeutic strategy for the treatment of multiple myeloma. We are